Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Non-Current Assets (2019 - 2025)

Historic Non-Current Assets for Benitec Biopharma (BNTC) over the last 7 years, with Q1 2025 value amounting to $1.2 million.

  • Benitec Biopharma's Non-Current Assets rose 8941.55% to $1.2 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.5 million, marking a year-over-year decrease of 144.19%. This contributed to the annual value of $536000.0 for FY2024, which is 2707.48% down from last year.
  • As of Q1 2025, Benitec Biopharma's Non-Current Assets stood at $1.2 million, which was up 8941.55% from $355000.0 recorded in Q4 2024.
  • In the past 5 years, Benitec Biopharma's Non-Current Assets ranged from a high of $1.5 million in Q3 2021 and a low of $355000.0 during Q4 2024
  • In the last 5 years, Benitec Biopharma's Non-Current Assets had a median value of $825000.0 in 2023 and averaged $874000.0.
  • Its Non-Current Assets has fluctuated over the past 5 years, first tumbled by 4010.75% in 2023, then skyrocketed by 8941.55% in 2025.
  • Quarter analysis of 5 years shows Benitec Biopharma's Non-Current Assets stood at $1.3 million in 2021, then tumbled by 30.7% to $930000.0 in 2022, then tumbled by 40.11% to $557000.0 in 2023, then tumbled by 36.27% to $355000.0 in 2024, then soared by 237.75% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q1 2025, $355000.0 for Q4 2024, and $439000.0 during Q3 2024.